3^rd World Biosimilars & Biologics Congress

Bioavailability and Bioequivalence

Bioavailability is defined as amount of drug available to the target site after systemic circulation and Bioequivalence is the similarity of two drugs must release the active ingredient at the same amount, rate &quality. In this process the new drugs are tested for their stability studies. The new formulations undergo the analytical process to get approved by the FDA as a safe and effective dosage form. It is frequent to compare new drug with the standard product as a reference.

• 
  In vivo & In vitro drug studies


• 
  Accelerated stability studies


• 
  Chromatography types and techniques


• 
  HPLC to monitor β-lactam plasma


• 
  Chemically, therapeutically and physically bioequivalent.


• 
  Cationic prodrugs as dual gene reagents